RxDoctor Payments Data

Michael Koch, MD

Urology · Indianapolis, INNPI 1821084252

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Mochida Pharmaceutical CO., LTD at 48.9% of the total. 2025 is the largest year on record at $518, more than ten times the $15 reported in 2019. That places this record below the midpoint for urology clinicians in IN, where the typical reported total is $3,350.

$1,023in general payments, 2019–2025

Across 9 payments — averaging $113.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mochida Pharmaceutical CO., LTD$500
  • Intuitive Surgical$207
  • Profound Medical Corp.$161
  • Conmed Corporation$109
  • Pfizer$28
  • Urogen Pharma, Inc.$18

What the payments were for

  • Consulting fees$50049%
  • Food & beverage$36936%
  • Education$15415%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Mochida Pharmaceutical CO., LTD1$500
Intuitive Surgical2$207
Profound Medical Corp.2$161
Conmed Corporation1$109
Pfizer2$28
Urogen Pharma, Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,023 in reported general payments places this provider in the 25th percentile of 272 urology providers in Indiana.

See all urology providers in Indiana

Medicare billing

Part B allowed, 2024
$106,590
Medicare patients
263
Services billed
494

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl55$792
Dutasteride21$768
Gentamicin Sulfate14$204
Ciprofloxacin Hcl21$101
Finasteride14$100

Paid to pharmacies, not to this prescriber.

Other urology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →